Tumor Virology, Immunology & Cellular Pathology

An oncovirus is an infection that can cause disease. any infection with a DNA or RNA genome causing disease and is synonymous with "tumor virus" or "cancer virus". DNA oncoviruses ordinarily divide into two groups of tumor silencer proteins: tumor proteins p53 and the retinoblastoma proteins (Rb). It is developmentally favourable for infections to inactivate p53 on the grounds that p53 can trigger cell cycle capture or apoptosis in contaminated cells when the infection endeavours to reproduce its DNA.

Cancer immunology is an interdisciplinary part of science that is worried about understanding the job of the resistant framework in the movement and improvement of disease; the most notable application is cancer growth immunotherapy, which uses the invulnerable framework as a treatment for disease.

 

  • Human oncoviruses
  • DNA viruses
  • RNA viruses
  • Tumor antigens
  • Cancer immunoediting
  • Mechanisms of tumor evasion from the immune response
  • Cancer immunology and chemotherapy

Related Conference of Tumor Virology, Immunology & Cellular Pathology

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Tumor Virology, Immunology & Cellular Pathology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in